–On track to report topline data from a clinical study of KB295 in patients with mild-to-moderate ulcerative colitis by end of third quarter–
–Kaleido and the COPD Foundation to collaborate on the development of KB109 in patients with COPD; plan to initiate…

Click here to view the original article.